Cancer epidemiology looks into the environmental, racial, and cultural influences to the occurrence of specific neoplasms
Cancer Incidence (2012)
WHO estimated 14.1M incidence of cancer worldwide leading to 8.2M deaths
Due to increasing population
WHO predicted that by the year 2035, the number of cancer cases and deaths worldwide will increase to 24M and 14.6M, respectively
Over several decades, there were noted decrease in the incidence of some specific cancers
Decrease in Lung Cancer
Due to decrease use of tobacco products
Decrease in death rates for Colorectal, Breast, and Prostate Cancers
Due to improved detection and treatment
Dominant risk factors for many common cancers
Carcinogens (naturally occurring or man-made)
Diet (Obesity)
Smoking
Alcohol Consumption
Reproductive History
Infectious Agents
A high fraction of cancers are potentially preventable
Carcinogens
Any substances that may cause cancer
In general the frequency of cancer increases with age
Due to accumulation of somatic mutations and decline in immune competence
10% of deaths due to cancer among children 15y/o and below
Cancers common in children
Leukemias
Lumphomas
Soft tissue and Bone sarcoma
CNS neoplasms
Acquired Predisposing Conditions
Conditions that increases the risk of cancer development
Examples of Acquired Predisposing Conditions
Chronic inflammation
Immunodeficiencies
Precursor lesions (Squamous metaplasia and dysplasia of bronchial mucosa, Endometrial hyperplasia and dysplasia, Leukoplakia, Villous adenoma of the colon)
Reversal or removal of precursor lesions may lower the cancer risk
Cancer Genes
Genes that are recurrently affected by genetic aberrations in cancers presumably because they contribute directly to the malignant behavior of cancer cells
Causative mutations in cancer genes
May be acquired by the action of environmental agents (carcinogens) or inherited in the germ line
Oncogenes
Genes that induce a transformed phenotype when expressed in cells, promote proliferation
Tumor suppressor genes
Genes that normally prevent uncontrolled growth, when mutated or lost, allows the transformed phenotype to develop
Tumor suppressor genes
Cell cycle regulator genes, checkpoint genes, apoptosis related genes (act as important breaks on cellular proliferation)
DNA repair proteins (responsible for sensing genomic damage, initiate and choreograph a "damage control response")
Genes that regulate apoptosis
Primarily act by enhancing survival rather than stimulating proliferation, protect against apoptosis
Genes that regulate interactions between tumor cells and host cell
May enhance or inhibit recognition of tumor cells by the host immune system
Driver Mutations
Mutations that alter the function of cancer genes and directly contribute to the development or progression of a given cancer
Passenger Mutations
Acquired mutations that occur at random and do not affect cellular behavior
Specific Mutations
Point mutations
Gene Rearrangements
Deletions
Gene Amplifications
Aneuploidy
MicroRNAs
Point mutations
Can either activate or inactivate the protein products of the affected genes
Gene Rearrangements
May be produced by chromosomal translocations or inversions, highly associated with neoplasms of the hematopoietic cells and other mesenchymal cells
Deletions
Deletion of specific regions of chromosome resulting in loss of particular tumor suppressor genes
Gene Amplifications
Proto-oncogenes may be converted to oncogenes by gene amplification with consequent overexpression and hyperactivity
Aneuploidy
Defined as a number of chromosomes that is not a multiple of the haploid state, frequently results from errors of the mitotic checkpoints
MicroRNAs
Non-coding, single-stranded RNAs that function as negative regulators of genes, inhibit gene expression posttranscriptionally by repressing translation, contribute to carcinogenesis by specifically targeting oncogenes and tumor suppressor genes
Carcinogenesis is a multi-step process resulting from the accumulation of multiple genetic alterations that collectively give rise to cancer
Hallmarks of Cancer
Self-sufficiency in growth signals
Insensitivity to growth-inhibitory signals
Altered cellular metabolism
Evasion of apoptosis
Limitless replicative potential (immortality)
Sustained angiogenesis
Invasion and metastasis
Evasion of immune surveillance
Carcinogenic Agents
Agents that inflict genetic damage
Classes of Carcinogenic Agents
Chemical Carcinogens
Radiant Carcinogens
Microbial Products
Direct-Acting Chemical Carcinogens
Require no metabolic conversion to become carcinogens, typically weak carcinogens, accumulation may induce carcinogenesis
Indirect-Acting Chemical Carcinogens
Require metabolic conversion to induce carcinogenesis